back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Recent filings | ||||||
| Filed 2026-09-23 17:09 Tx date 2026-04-01 |
$N/A
BRIAPRO THERAPEUTICS CORP. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+359,000 vol |
359,000 | |
| Filed 2026-09-23 17:07 Tx date 2023-09-20 |
$N/A
BRIAPRO THERAPEUTICS CORP. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2026-09-23 17:06 Tx date 2026-04-01 |
$N/A
BRIAPRO THERAPEUTICS CORP. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+359,000 vol |
||
| Older filings | ||||||
| Filed 2026-04-08 16:21 Tx date 2026-04-01 |
$N/A
BRIAPRO THERAPEUTICS CORP. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+359,000 vol |
||
| Filed 2026-09-04 13:16 Tx date 2026-07-07 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+45,000 vol |
60,000 | |
| Filed 2026-09-04 13:15 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+15,000 vol |
15,000 | |
| Filed 2026-07-07 13:50 Tx date 2026-07-07 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+45,000 vol |
||
| Filed 2025-10-02 16:18 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+15,000 vol |
||
| Filed 2026-07-07 13:50 Tx date 2026-07-07 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+45,000 vol |
60,000 | |
| Filed 2026-04-08 16:21 Tx date 2026-04-01 |
$N/A
BRIAPRO THERAPEUTICS CORP. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+359,000 vol |
359,575 | |
| Filed 2025-10-02 16:18 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+15,000 vol |
15,000 | |
| Filed 2025-10-02 16:16 Tx date 2020-12-01 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-02 11:23 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-34 vol |
4 | |
| Filed 2025-09-02 11:22 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-6,901 vol |
766 | |
| Filed 2025-01-29 17:28 Tx date 2025-01-27 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-107,333 vol |
7,667 | |
| Filed 2025-01-29 17:27 Tx date 2025-01-27 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-537 vol |
38 | |
| Filed 2023-06-20 14:04 Tx date 2023-06-20 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$241,200
+40,000 vol $6.03 each |
115,000 | |
| Filed 2023-06-20 13:59 Tx date 2020-12-01 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
75,000 | ||
| Filed 2022-07-22 14:43 Tx date 2020-12-01 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
575 | ||
| Filed 2022-07-06 12:27 Tx date 2022-07-06 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-100,000 vol |
0 | |